Fatty acids and their therapeutic potential in neurological disorders

Neurochemistry International

Volumn 95, Issue , 2016, Pages 75-84

  Lei, Enie ^a   Vacy, Kristina ^a   Boon, Wah Chin ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FORMIC ACID; ICOSAPENTAENOIC ACID; LAURIC ACID; LINOLEIC ACID; MEDIUM CHAIN FATTY ACID; OCTANOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROPIONIC ACID; VALERIC ACID; VALPROIC ACID;

ADVERSE OUTCOME; ALZHEIMER DISEASE; AUTISM; DIET SUPPLEMENTATION; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLISM; NERVOUS SYSTEM DISEASES; PATHOLOGY; PROCEDURES;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84961800975     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.02.014     Document Type: Review

References (119)

1. R. Agrawal, and F. Gomez-Pinilla 'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition J. Physiol. 590 Pt 10 2012 2485 2499
2. G.P. Amminger, G.E. Berger, M.R. Schäfer, C. Klier, M.H. Friedrich, and M. Feucht Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study Biol. Psychiatry 61 4 2007 Feb 15 551 553
3. L. Belayev, L. Khoutorova, K.D. Atkins, and N.G. Bazan Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia Stroke 40 9 2009 3121 3126 10.1161/strokeaha.109.555979
4. R. Berni Canani, M. Di Costanzo, and L. Leone The epigenetic effects of butyrate: potential therapeutic implications for clinical practice Clin. Epigenetics 4 1 2012 4
5. T.L. Blasbalg, J.R. Hibbeln, C.E. Ramsden, S.F. Majchrzak, and R.R. Rawlings Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century Am. J. Clin. Nutr. 93 5 2011 950 962 10.3945/ajcn.110.006643
6. M.W. Bourassa, I. Alim, S.J. Bultman, and R.R. Ratan Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health? 2016 Feb 8. pii: S0304-3940(16)30077-5 Neurosci. Lett. 2016 10.1016/j.neulet.2016.02.009 [Epub ahead of print]
7. S.A. Brigandi, H. Shao, S.Y. Qian, Y. Shen, B.L. Wu, and J.X. Kang Autistic children exhibit decreased levels of essential Fatty acids in red blood cells Int. J. Mol. Sci 16 5 2015 May 4 10061 10076 10.3390/ijms160510061
8. B. Burton On the propyl derivatives and decomposition products of ethylacetoacetate Am. Chem. J. 3 1882 385 395
9. F. Calon, G.P. Lim, T. Morihara, F. Yang, O. Ubeda, N. Salem Jr., S.A. Frautschy, and G.M. Cole Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease Eur. J. Neurosci. 22 3 2005 617 626
10. E.S. Chambers, A. Viardot, A. Psichas, D.J. Morrison, K.G. Murphy, S.E. Zac-Varghese, and G. Frost Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults Gut 64 11 2015 1744 1754
11. Z. Chen, and C. Zhong Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies Prog. Neurobiol 108 2013 Sep 21 43 10.1016/j.pneurobio.2013.06.004
12. T. Chomiak, N. Turner, and B. Hu What we have learned about autism spectrum disorder from valproic acid Patholog. Res. Int. 2013 2013 712758 10.1155/2013/712758
13. M.G. Codagnone, M.F. Podestá, N.A. Uccelli, and A. Reinés Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and Hippocampus in the valproic acid rat model of autism Dev. Neurosci. 37 2015 215 231 10.1159/000375489
14. L.C. Costantini, L.J. Barr, J.L. Vogel, and S.T. Henderson Hypometabolism as a therapeutic target in Alzheimer's disease BMC Neurosci. 2 9 Suppl 2008 Dec 3 S16 10.1186/1471-2202-9-S2-S16
15. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves, J. Vinera, C. Zitoun, A. Duchampt, and G. Mithieux Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits Cell 156 1-2 2014 84 96
16. S. Dehghan, S. Asadi, M. Hajikaram, M. Soleimani, S.J. Mowla, Y. Fathollahi, and M. Javan Exogenous Oct4 in combination with valproic acid increased neural progenitor markers: an approach for enhancing the repair potential of the brain Life Sci. 122 2015 108 115 10.1016/j.lfs.2014.12.007
17. S.E. Dekker, M. Sillesen, T. Bambakidis, A.V. Andjelkovic, G. Jin, B. Liu, and H.B. Alam Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock J. Surg. Res. 190 1 2014 312 318 10.1016/j.jss.2014.02.049
18. F. Ding, J. Yao, J.R. Rettberg, S. Chen, and R.D. Brinton Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention PLoS One 8 11 2013 e79977 10.1371/journal.pone.0079977
19. D.R. Donohoe, N. Garge, X. Zhang, W. Sun, T.M. O'Connell, M.K. Bunger, and S.J. Bultman The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian Colon Cell Metab. 13 5 2011 517 526 10.1016/j.cmet.2011.02.018
20. J. Farquharson, F. Cockburn, W.A. Patrick, E.C. Jamieson, and R.W. Logan Infant cerebral cortex phospholipid fatty-acid composition and diet Lancet 340 8823 1992 810 813
21. F.G. De Felice, M.V. Lourenco, and S.T. Ferreira How does brain insulin resistance develop in Alzheimer's disease? Alzheimers Dement. 10 1 Suppl 2014 S26 32 10.1016/j.jalz.2013.12.004
22. W.M. Fernando, I.J. Martins, K.G. Goozee, C.S. Brennan, V. Jayasena, and R.N. Martins The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action Br. J. Nutr. 2015 1 14 10.1017/s0007114515001452
23. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N.W. Kowall, R.R. Ratan, R. Luthi-Carter, and S.M. Hersch Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J. Neurosci 23 28 2003 Oct 15 9418 9427
24. Y. Freund Levi, I. Vedin, T. Cederholm, H. Basun, G. Faxén Irving, M. Eriksdotter, E. Hjorth, M. Schultzberg, B. Vessby, L.O. Wahlund, N. Salem Jr., and J. Palmblad Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study J. Intern. Med 275 4 2014 Apr 428 436 10.1111/joim.12166
25. G. Frost, M.L. Sleeth, M. Sahuri-Arisoylu, B. Lizarbe, S. Cerdan, L. Brody, and J.D. Bell The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism Nat. Commun. 5 3611 2014
26. R.E. Frye, S. Rose, J. Slattery, and D.F. MacFabe Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome Microb. Ecol. Health Dis. 26 2015 27458 10.3402/mehd.v26.27458
27. H. Funato, S. Oda, J. Yokofujita, H. Igarashi, and M. Kuroda Fasting and high-fat diet alter histone deacetylase expression in the medial hypothalamus PLoS ONE 6 4 2011 Article Number: e18950. Date of Publication: 2011
28. B. Gidal, N. Spencer, M. Maly, M. Pitterle, E. Williams, M. Collins, and J. Jones Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration Neurology 44 8 1994 1418 1422
29. N. Govindarajan, R.C. Agis-Balboa, J. Walter, F. Sananbenesi, and A. Fischer Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression J. Alzheimers Dis 26 1 2011 187 197 10.3233/JAD-2011-110080
30. D.R. Grayson, M. Kundakovic, and R.P. Sharma Is there a future for Histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol. Pharmacol. 77 2 2010 126 135 10.1124/mol.109.061333
31. M.O. Grimm, V.C. Zimmer, J. Lehmann, H.S. Grimm, and T. Hartmann The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease Biomed. Res. Int. 2013 2013 814390 10.1155/2013/814390
32. D. Grotto, and E. Zied The standard American diet and its relationship to the health status of Americans Nutr. Clin. Pract. 25 6 2010 603 612
33. J. Guest, M. Garg, A. Bilgin, and R. Grant Relationship between central and peripheral fatty acids in humans Lipids Health Dis 12 2013 May 28 79 10.1186/1476-511X-12-79
34. R.A. Haast, and A.J. Kiliaan Impact of fatty acids on brain circulation, structure and function Prostagl. Leukot. Essent. Fat. Acids 92 2015 3 14 10.1016/j.plefa.2014.01.002
35. E. Hahnen, J. Hauke, C. Trankle, I.Y. Eyupoglu, B. Wirth, and I. Blumcke Histone deacetylase inhibitors: possible implications for neurodegenerative disorders Expert Opin. Investig. Drugs 17 2 2008 169 184 10.1517/13543784.17.2.169
36. J.A. Hamilton Transport of fatty acids across membranes by the diffusion mechanism. Prostaglandins Leukot. Essent Fatty Acids 60 5-6 1999 May-Jun 291 297
37. I.F. Harrison, and D.T. Dexter Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol. Ther. 140 1 2013 34 52
38. M. Hashimoto, and S. Hossain Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease J. Pharmacol. Sci. 116 2 2011 150 162
39. S.G. Hasselbalch, G.M. Knudsen, J. Jakobsen, L.P. Hageman, S. Holm, and O.B. Paulson Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans Am. J. Physiol. 268 6 Pt 1 1995 E1161 1166
40. S.T. Henderson, J.L. Vogel, L.J. Barr, F. Garvin, J.J. Jones, and L.C. Costantini Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial Nutr. Metab. (Lond) 6 2009 31 10.1186/1743-7075-6-31
41. L. Hertz, Y. Chen, and H.S. Waagepetersen Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, beta-amyloid toxicity, and astrocyte function J. Neurochem. 134 1 2015 7 20 10.1111/jnc.13107
42. S.H. Hong, L. Khoutorova, N.G. Bazan, and L. Belayev Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats Exp. Transl. Stroke Med. 7 1 2015 3 10.1186/s13231-014-0012-0
43. L.A. Horrocks, and A.A. Farooqui Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function Prostagl. Leukot. Essent. Fat. Acids 70 4 2004 361 372 10.1016/j.plefa.2003.12.011
44. M.K. Horwitt, C.C. Harvey, and B. Century Effect of dietary fats on fatty acid composition of human erythrocytes and chick cerebella Science 130 3380 1959 917 918
45. T. Hosono, K. Nishitsuji, T. Nakamura, C.-G. Jung, M. Kontani, H. Tokuda, and M. Michikawa Arachidonic acid diet attenuates brain Aβ deposition in Tg2576 mice Brain Res. 1613 2015 92 99 10.1016/j.brainres.2015.04.005
46. J. Huuskonen, T. Suuronen, T. Nuutinen, S. Kyrylenko, and A. Salminen Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids Br. J. Pharmacol. 141 5 2004 874 880 10.1038/sj.bjp.0705682
47. C.I. Janssen, and A.J. Kiliaan Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration Prog. Lipid Res. 53 2014 1 17
48. G. Jin, M. Duggan, A. Imam, M.A. Demoya, M. Sillesen, J. Hwabejire, and H.B. Alam Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury J. Trauma Acute Care Surg. 73 6 2012 1461 1470
49. Y. Kamisah, V. Periyah, K.T. Lee, N. Noor-Izwan, A. Nurul-Hamizah, B.S. Nurul-Iman, and H.M. Qodriyah Cardioprotective effect of virgin coconut oil in heated palm oil diet-induced hypertensive rats Pharm. Biol. 2015 1 7 10.3109/13880209.2014.971383
50. F. Kamp, N. Kizilbash, B.E. Corkey, P.O. Berggren, and J.A. Hamilton Sulfonylureas rapidly cross phospholipid bilayer membranes by a free-diffusion mechanism Diabetes 52 10 2003 Oct 2526 2531
51. J. Kang, and E. Kim Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors Front. Mol. Neurosci. 8 2015 17 10.3389/fnmol.2015.00017
52. L. Kelly, B. Grehan, A.D. Chiesa, S.M. O'Mara, E. Downer, G. Sahyoun, and M.A. Lynch The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat Neurobiol. Aging 32 12 2011 10.1016/j.neurobiolaging.2010.04.001 2318.e2311-2318.e2315
53. S.L. Kesl, A.M. Poff, N.P. Ward, T.N. Fiorelli, C. Ari, A.J. Van Putten, J.W. Sherwood, P. Arnold, and D.P. D'Agostino Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats Nutr. Metabolism 13 1 2016 1 15
54. S. Koenig, T. Gerstner, A. Keller, M. Teich, E. Longin, and C.E. Dempfle High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study Blood Coagul. Fibrinolysis 19 5 2008 375 382
55. M. Lewis, P. Ghassemi, and J. Hibbeln Therapeutic use of omega-3 fatty acids in severe head trauma Am. J. Emerg. Med. 31 1 2013 273.e5 273.e8 10.1016/j.ajem.2012.05.014
56. P.V. Licciardi, S.S. Wong, M.L. Tang, and T.C. Karagiannis Epigenome targeting by probiotic metabolites Gut Pathog. 2 1 2010 1757 4749
57. P.V. Licciardi, K. Ververis, and T.C. Karagiannis Histone deacetylase inhibition and dietary short-chain fatty acids ISRN Allergy 2011 2011 869647 10.5402/2011/869647
58. Y. Lin, M. Xu, J. Wan, S. Wen, J. Sun, H. Zhao, and M. Lou Docosahexaenoic acid attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal cerebral ischemia in rats Neuroscience 301 2015 471 479
59. Q. Lu, Y.T. Yang, C.S. Chen, M. Davis, J.C. Byrd, M.R. Etherton, and C.S. Chen Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors J. Med. Chem. 47 2 2004 467 474 10.1021/jm0303655
60. J. Lunn, and J.L. Buttriss Carbohydrates and dietary fibre Nutr. Bull. 32 1 2007 21 64 10.1111/j.1467-3010.2007.00616.x
61. D. Macfabe Autism: metabolism, mitochondria, and the microbiome Glob. Adv. Health Med. 2 6 2013 52 66 10.7453/gahmj.2013.089
62. A.C. Marcal, J.P. Camporez, T.M. Lima-Salgado, D.E. Cintra, E.H. Akamine, L.M. Ribeiro, and C.R. Carvalho Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets Br. J. Nutr. 109 12 2013 2154 2165 10.1017/s0007114512004576
63. B. Marten, M. Pfeuffer, and J. Schrezenmeir Medium-chain triglycerides Int. Dairy J. 16 11 2006 1374 1382
64. W. Maruyama, M. Shaomoto-Nagai, Y. Kato, S. Hisaka, T. Osawa, and M. Naoi Role of lipid peroxide in the neurodegenerative disorders Subcell. Biochem. 77 2014 127 136 10.1007/978-94-007-7920-4-11
65. R.W. Mitchell, N.H. On, M.R. Del Bigio, D.W. Miller, and G.M. Hatch Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells J. Neurochem. 117 4 2011 735 746
66. B. Monti, V. Gatta, F. Piretti, S.S. Raffaelli, M. Virgili, and A. Contestabile Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein Neurotox. Res. 17 2 2010 130 141 10.1007/s12640-009-9090-5
67. G.A. Mostafa, H.Y. El-Khashab, and L.Y. Al-Ayadhi A possible association between elevated serum levels of brain-specific auto-antibodies and reduced plasma levels of docosahexaenoic acid in autistic children J. Neuroimmunol 280 2015 Mar 15 16 20 10.1016/j.jneuroim.2015.01.009
68. C.P. Müller, M. Reichel, C. Mühle, C. Rhein, E. Gulbins, and J. Kornhuber Brain membrane lipids in major depression and anxiety disorders Biochim. Biophys. Acta 1851 8 2015 Aug 1052 1065 10.1016/j.bbalip.2014.12.014
69. F. Nafar, and K.M. Mearow Coconut oil attenuates the effects of amyloid-beta on cortical neurons in vitro J. Alzheimers Dis. 39 2 2014 233 237 10.3233/jad-131436
70. P. Nestel, P. Clifton, D. Colquhoun, M. Noakes, T.A. Mori, D. Sullivan, and B. Thomas Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease Heart Lung Circ 24 8 2015 Aug 769 779 10.1016/j.hlc.2015.03.020
71. J.C. Newman, and E. Verdin Ketone bodies as signaling metabolites. Trends Endocrinol Metab 25 1 2014 Jan 42 52 10.1016/j.tem.2013.09.002
72. A.C. Nilsson, E.M. Östman, K.E. Knudsen, J.J. Holst, and I.M. Björck A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning J. Nutr 140 11 2010 Nov 1932 1936 10.3945/jn.110.123604
73. E.M. Novak, R.A. Dyer, and S.M. Innis High dietary ω-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth Brain Res. 1237 2008 136 145 10.1016/j.brainres.2008.07.107
74. L. Packer, H.J. Tritschler, and K. Wessel Neuroprotection by the metabolic antioxidant alpha-lipoic acid Free Radic. Biol. Med. 22 1-2 1997 359 378
75. Y. Pan, M.J. Scanlon, Y. Owada, Y. Yamamoto, C.J. Porter, and J.A. Nicolazzo Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid Mol. Pharm. 30 2015 30
76. G.M. Pasinetti Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications Planta Med. 78 15 2012 1614 1619
77. H. Pélerin, M. Jouin, M.S. Lallemand, J.M. Alessandri, S.C. Cunnane, B. Langelier, and P. Guesnet Gene expression of fatty acid transport and binding proteins in the blood-brain barrier and the cerebral cortex of the rat: differences across development and with different DHA brain status Prostagl. Leukot. Essent. Fat. Acids 91 5 2014 213 220
78. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 10 2002 695 714
79. D. Petrov, I. Pedros, G. Artiach, F.X. Sureda, E. Barroso, M. Pallas, and A. Camins High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiencies contribute to Alzheimer disease pathology in rodents Biochim. Biophys. Acta 1852 9 2015 1687 1699 10.1016/j.bbadis.2015.05.004
80. M.A. Phillips, C.E. Childs, P.C. Calder, and P.J. Rogers No effect of Omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer's disease: a randomised controlled trial Int. J. Mol. Sci. 16 10 2015 24600 24613
81. P. Politi, H. Cena, M. Comelli, G. Marrone, C. Allegri, E. Emanuele, and S. Ucelli di Nemi Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study Arch. Med. Res 39 7 2008 Oct 682 685 10.1016/j.arcmed.2008.06.005
82. P.L. Prior, and J.C. Galduróz (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders Adv. Nutr 3 3 2012 May 1 257 265 10.3945/an.111.001693
83. H. Qing, G. He, P.T. Ly, C.J. Fox, M. Staufenbiel, F. Cai, and W. Song Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models J. Exp. Med. 205 12 2008 2781 2789 10.1084/jem.20081588
84. S.I. Rapoport Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo Prostagl. Leukot. Essent. Fat. Acids 88 1 2013 79 85
85. C.J. Rebello, J.N. Keller, A.G. Liu, W.D. Johnson, and F.L. Greenway Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: a randomized controlled trial BBA Clin. Jan. 16 3 2015 123 125 10.1016/j.bbacli.2015.01.001
86. M.A. Reger, S.T. Henderson, C. Hale, B. Cholerton, L.D. Baker, G.S. Watson, K. Hyde, D. Chapman, and S. Craft Effects of beta-hydroxybutyrate on cognition in memory-impaired adults Neurobiol. Aging 25 3 2004 311 314
87. K.J. Reilly, and J.L. Rombeau Metabolism and potential clinical applications of short-chain fatty acids Clin. Nutr. 12 1993 S97 S105 10.1016/s0261-5614(09)90016-4
88. C.S. Rosenfeld Microbiome disturbances and autism spectrum disorders Drug Metab. Dispos. 43 10 2015 Oct 1557 1571 10.1124/dmd.115.063826
89. B. Schnuriger, K. Inaba, G.A. Abdelsayed, T. Lustenberger, B.M. Eberle, G. Barmparas, and D. Demetriades The impact of platelets on the progression of traumatic intracranial hemorrhage J. Trauma 68 4 2010 881 885
90. A. Schwiertz, D. Taras, K. Schafer, S. Beijer, N.A. Bos, C. Donus, and P.D. Hardt Microbiota and SCFA in lean and overweight healthy subjects Obesity 18 1 2010 190 195
91. B. Sears, J. Bailes, and B. Asselin Therapeutic uses of high-dose omega-3 fatty acids to treat comatose patients with severe brain injury PharmaNutrition 1 2013 86 89
92. A. Sekhavat, J.M. Sun, and J.R. Davie Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate Biochem. Cell Biol. 85 6 2007 Dec 751 758
93. T. Shimazu, M.D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C.A. Grueter, H. Lim, L.R. Saunders, R.D. Stevens, C.B. Newgard, R.V. Farese Jr., R. de Cabo, S. Ulrich, K. Akassoglou, and E. Verdin Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor Science 339 6116 2013 211 214 10.1126/science.1227166
94. S.D. Smid, J.L. Maag, and I.F. Musgrave Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical Food Funct. 3 12 2012 1242 1250 10.1039/c2fo30075c
95. P.J. Sorgi, E.M. Hallowell, H.L. Hutchins, and B. Sears Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder Nutr. J. 6 2007 16
96. H. Sprecher Metabolism of highly unsaturated n-3 and n-6 fatty acids Biochimica Biophysica Acta (BBA) - Mol. Cell Biol. Lipids 1486 2-3 2000 219 231 10.1016/S1388-1981(00)00077-9
97. R. St Laurent, L.M. O'Brien, and S.T. Ahmad Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease Neuroscience 246 2013 382 390 10.1016/j.neuroscience.2013.04.037
98. A.V. Steckert, C.M. Comim, D.M. Igna, D. Dominguini, B.P. Mendonça, F. Ornell, G.D. Colpo, C. Gubert, F. Kapczinski, T. Barichello, J. Quevedo, and F. Dal-Pizzol Effects of sodium butyrate on aversive memory in rats submitted to sepsis Neurosci. Lett 595 2015 May 19 134 138 10.1016/j.neulet.2015.04.019
99. R.M. Stilling, and A. Fischer The role of histone acetylation in age-associated memory impairment and Alzheimer's disease Neurobiol. Learn Mem. 96 1 2011 19 26
100. A.M. Stranahan, E.D. Norman, K. Lee, R.G. Cutler, R. Telljohann, J.M. Egan, and M.P. Mattson Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats Hippocampus 18 11 2008 1085 1088 10.1002/hipo.20470
101. S. Suda, K. Katsura, T. Kanamaru, M. Saito, and Y. Katayama Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation Eur. J. Pharmacol. 707 1-3 2013 26 31 10.1016/j.ejphar.2013.03.020
102. S. Suda, M. Ueda, C. Nito, Y. Nishiyama, S. Okubo, A. Abe, and K. Kimura Valproic acid ameliorates ischemic brain injury in hyperglycemic rats with permanent middle cerebral occlusion Brain Res. 1606 2015 1 8 10.1016/j.brainres.2015.02.013
103. H. Sun, T. Jiang, S. Wang, B. He, Y. Zhang, D. Piao, and P. Han The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance Diabetes Res. Clin. Pract. 102 3 2013 183 192 10.1016/j.diabres.2013.10.010
104. D.L. Topping, and P.M. Clifton Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides Physiol. Rev. 81 3 2001 1031 1064
105. S.S. Valvassori, W.R. Resende, J. Lopes-Borges, E. Mariot, G.C. Dal-Pont, M.F. Vitto, G. Luz, C.T. de Souza, and J. Quevedo Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway J. Psychiatr. Res 65 2015 Jun 63 70 10.1016/j.jpsychires.2015.04.009
106. S. Vancassel, G. Durand, C. Barthélémy, B. Lejeune, J. Martineau, D. Guilloteau, C. Andrès, and S. Chalon Plasma fatty acid levels in autistic children Prostaglandins Leukot. Essent. Fatty Acids 65 1 2001 Jul 1 7
107. I. Van der Auwera, S. Wera, F. Van Leuven, and S.T. Henderson A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease Nutr. Metabolism 2 2005 10.1186/1743-7075-2-28 28-28
108. K. van Elst, H. Bruining, B. Birtoli, C. Terreaux, J.K. Buitelaar, and M.J. Kas Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders Neurosci. Biobehav Rev. 45 2014 369 378
109. R.G. Voigt, M.W. Mellon, S.K. Katusic, A.L. Weaver, D. Matern, B. Mellon, C.L. Jensen, and W.J. Barbaresi Dietary docosahexaenoic acid supplementation in children with autism J. Pediatr. Gastroenterol. Nutr 58 6 2014 Jun 715 722 10.1097/MPG.0000000000000260
110. A. Vysakh, M. Ratheesh, T.P. Rajmohanan, C. Pramod, S. Premlal, B. Girish kumar, and P.I. Sibi Polyphenolics isolated from virgin coconut oil inhibits adjuvant induced arthritis in rats through antioxidant and anti-inflammatory action Int. Immunopharmacol. 20 1 2014 124 130 10.1016/j.intimp.2014.02.026
111. E.A. Winkler, Y. Nishida, A.P. Sagare, S.V. Rege, R.D. Bell, D. Perlmutter, and B.V. Zlokovic GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration Nat. Neurosci. 18 4 2015 521 530 10.1038/nn.3966
112. E. Wisker, A. Maltz, and W. Feldheim Metabolizable energy of diets low or high in dietary fiber from cereals when eaten by humans J. Nutr. 118 8 1988 945 952
113. S. Wu, Y. Ding, F. Wu, R. Li, J. Hou, and P. Mao Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis Neurosci. Biobehav Rev. 48 2015 1 9 10.1016/j.neubiorev.2014.11.008
114. K. Xu, X.L. Dai, H.C. Huang, and Z.F. Jiang Targeting HDACs: a promising therapy for Alzheimer's disease Oxid. Med. Cell Longev. 2011 2011 143269 10.1155/2011/143269
115. C.M. Yates, P.C. Calder, and G. Ed Rainger Pharmacology and therapeutics of Omega-3 polyunsaturated fatty acids in chronic inflammatory disease Pharmacol Ther 141 3 2014 272 282
116. S.K. Yeap, B.K. Beh, N.M. Ali, H.M. Yusof, W.Y. Ho, S.P. Koh, and K. Long Antistress and antioxidant effects of virgin coconut oil Exp. Ther. Med. 9 1 2015 39 42 10.3892/etm.2014.2045
117. B. Yetimler, G. Ulusoy, T. Çelik, and E. Jakubowska-Doǧru Differential effect of age on the brain fatty acid levels and their correlation with animal cognitive status in mice. Pharmacol. Biochem. Behav 103 1 2012 Nov 53 59
118. K. Yui, M. Koshiba, S. Nakamura, and Y. Kobayashi Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial J. Clin. Psychopharmacol 32 2 2012 Apr 200 206 10.1097/JCP.0b013e3182485791
119. K. Yurko-Mauro, D.D. Alexander, and M.E. Van Elswyk Docosahexaenoic acid and adult memory: a systematic review and meta-analysis PLoS One 10 3 2015 e0120391 10.1371/journal.pone.0120391